{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:15:03Z","timestamp":1788430503206,"version":"build-2803163510"},"reference-count":41,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Foundation of Chongqing General Hospital","award":["Y2023YXYJZDXM03"],"award-info":[{"award-number":["Y2023YXYJZDXM03"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072976"],"award-info":[{"award-number":["82072976"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82072976"],"award-info":[{"award-number":["82072976"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: OS is characterized by marked tumor heterogeneity, stemness-associated phenotypes, metastatic potential, and poor prognosis. FZD4 is an important Wnt signaling receptor involved in stem cell regulation and tumor progression, but its role and microRNA-mediated regulation in OS remain unclear. The aim of this study was to investigate the relationship between FZD4 expression, OS stemness, malignant progression, and upstream microRNA regulation. Methods:Human OS single-cell RNA sequencing data were analyzed using Seurat, CytoTRACE, and Monocle2. Tumor cell subpopulations, developmental potential, and pseudotime trajectories were evaluated. Functional enrichment analyses were performed to identify pathways associated with high FZD4 expression. MicroRNA\u2013mRNA interaction analysis was used to predict upstream regulatory microRNAs, and immunohistochemistry, Western blotting, and in vitro and in vivo experiments were performed for validation. Results: FZD4 was mainly enriched in OS tumor cell subpopulations and was significantly associated with poor prognosis. Tumor cells with high FZD4 expression showed increased developmental potential, stemness features, and enrichment in early developmental states. Functional enrichment analysis indicated activation of epithelial\u2013mesenchymal transition, angiogenesis, inflammatory response, KRAS signaling, hypoxia, glycolysis, and Wnt-related pathways. Clinical validation confirmed elevated expression of FZD4, OCT4, and SOX2 in OS tissues. FZD4 knockdown inhibited OS cell stem-like phenotypes and malignant behaviors, proliferation, and migration, while miR-424-5p suppressed these malignant phenotypes by targeting FZD4. Importantly, rescue experiments demonstrated that restoration of FZD4 substantially reversed the inhibitory effects of miR-424-5p mimics on sphere formation, migration\/invasion, proliferation, and stemness-associated cell populations. Conclusions: Our findings identify miR-424-5p as an upstream suppressor of FZD4 and demonstrate that the miR-424-5p\/FZD4 axis regulates stem-like and malignant phenotypes of OS cells, at least partly through Wnt\/\u03b2-catenin signaling. This axis may represent a potential therapeutic target for OS.<\/jats:p>","DOI":"10.3390\/cancers18172846","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:20:43Z","timestamp":1788427243000},"page":"2846","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-424-5p Regulates Stem-like and Malignant Phenotypes in Osteosarcoma by Targeting FZD4"],"prefix":"10.3390","volume":"18","author":[{"given":"Jingjin","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[{"name":"A Campus Clinic, Hospital of Chongqing University, Chongqing 400044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsheng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"},{"name":"Department of Orthopaedic Trauma, Chongqing General Hospital, Chongqing University, Chongqing 401147, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxue","family":"Quan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","article-title":"Osteosarcoma","volume":"21","author":"Ritter","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"OS Incidence and Survival Rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Odri, G.A., Tchicaya-Bouanga, J., Yoon, D.J.Y., and Modrowski, D. (2022). Metastatic Progression of OSs: A Review of Current Knowledge of Environmental versus Oncogenic Drivers. Cancers, 14.","DOI":"10.3390\/cancers14020360"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"OS: Current Treatment and a Collaborative Pathway to Success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14737140.2018.1413939","article-title":"Current and Future Therapeutic Approaches for OS","volume":"18","author":"Harrison","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1096\/fj.10-179036","article-title":"Human Primary Bone Sarcomas Contain CD133+ Cancer Stem Cells Displaying High Tumorigenicity in Vivo","volume":"25","author":"Tirino","year":"2011","journal-title":"FASEB J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3631764","DOI":"10.1155\/2016\/3631764","article-title":"OS: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies","volume":"2016","author":"Abarrategi","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/onc.2011.405","article-title":"Sox2 Maintains Self Renewal of Tumor-Initiating Cells in OSs","volume":"31","author":"Seo","year":"2012","journal-title":"Oncogene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1038\/ncomms7411","article-title":"Sox2 Antagonizes the Hippo Pathway to Maintain Stemness in Cancer Cells","volume":"6","author":"Bayin","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4103\/jomfp.JOMFP_22_20","article-title":"SOX2, OCT4 and NANOG: The Core Embryonic Stem Cell Pluripotency Regulators in Oral Carcinogenesis","volume":"24","author":"Swain","year":"2020","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-Cell RNA Landscape of Intratumoral Heterogeneity and Immunosuppressive Microenvironment in Advanced OS","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Guo, J., Tang, H., Huang, P., Guo, J., Shi, Y., Yuan, C., Liang, T., and Tang, K. (2022). Single-Cell Profiling of Tumor Microenvironment Heterogeneity in OS Identifies a Highly Invasive Subcluster for Predicting Prognosis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.732862"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-024-01598-7","article-title":"A Single-Cell and Spatially Resolved Atlas of Human OSs","volume":"17","author":"Zheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target Recognition and Regulatory Functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA Biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in Cancer: Biomarkers, Functions and Therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gupta, A., Mehrotra, A., Sood, A., Sharma, B., Yadav, V., Kaur, G., Sak, K., Satapathy, S.R., and Tuli, H.S. (2025). MicroRNAs at the Crossroad of Cancer Therapeutics: Insights from WNT Signaling & Flavonoids. Front. Mol. Biosci., 12.","DOI":"10.3389\/fmolb.2025.1616221"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/Beta-Catenin Signaling in Development and Disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2007.02.007","article-title":"Wnt\/Beta-Catenin Signaling in Cancer Stemness and Malignant Behavior","volume":"19","author":"Fodde","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.27746","article-title":"Frizzled Homolog Proteins, microRNAs and Wnt Signaling in Cancer","volume":"132","author":"Ueno","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-030-43085-6_8","article-title":"Wnt Signaling in OS","volume":"1258","author":"Singla","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17570","DOI":"10.18632\/oncotarget.4100","article-title":"Aberrant Activation of Wnt\/\u03b2-Catenin Signaling Drives Proliferation of Bone Sarcoma Cells","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1002\/jcb.26011","article-title":"Wnt\/\u03b2-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human OS Cell Types","volume":"118","author":"Vega","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1158\/0008-5472.CAN-10-1495","article-title":"Frizzled 4 Regulates Stemness and Invasiveness of Migrating Glioma Cells Established by Serial Intracranial Transplantation","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41419-021-04339-7","article-title":"EIF4A3-Induced Circular RNA PRKAR1B Promotes OS Progression by miR-361-3p-Mediated Induction of FZD4 Expression","volume":"12","author":"Feng","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Liu, Y., He, M., Tang, H., Xie, T., Lin, Y., Liu, S., Liang, J., Li, F., Luo, K., and Yang, M. (2024). Single-Cell and Spatial Transcriptomics Reveal Metastasis Mechanism and Microenvironment Remodeling of Lymph Node in OS. BMC Med., 22.","DOI":"10.1186\/s12916-024-03319-w"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10495-023-01922-5","article-title":"Single-Cell Aggrephagy-Related Patterns Facilitate Tumor Microenvironment Intercellular Communication, Influencing OS Progression and Prognosis","volume":"29","author":"Jiang","year":"2024","journal-title":"Apoptosis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and Protein-RNA Interaction Networks from Large-Scale CLIP-Seq Data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2012.09.003","article-title":"New Targets and Approaches in OS","volume":"137","author":"Gill","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-Cell Transcriptional Diversity Is a Hallmark of Developmental Potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT Signalling Pathways as Therapeutic Targets in Cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin Signaling, Disease, and Emerging Therapeutic Modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/0008-5472.CAN-10-0244","article-title":"FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells","volume":"70","author":"Gupta","year":"2010","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and Genetics. MicroRNAs En Route to the Clinic: Progress in Validating and Targeting microRNAs for Cancer Therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental Regulation of Tumor Progression and Metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Corre, I., Verrecchia, F., Crenn, V., Redini, F., and Trichet, V. (2020). The OS Microenvironment: A Complex But Targetable Ecosystem. Cells, 9.","DOI":"10.3390\/cells9040976"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed Graph Embedding Resolves Complex Single-Cell Trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Qiu, Y., Pu, C., Wang, C., and Quan, Z. (2025). The RNA-Binding Protein RBMX Mediates the Immunosuppressive Microenvironment of OS by Regulating CD8+T Cells. Cancers, 17.","DOI":"10.3390\/cancers17172928"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the Immune Microenvironment of OS: The Outlook for OS Treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Taylor, A.M., Sheng, J., Ng, P.K.S., Harder, J.M., Kumar, P., Ahn, J.Y., Cao, Y., Dzis, A.M., Jillette, N.L., and Goodspeed, A. (2025). Immunosuppressive Tumor Microenvironment of OS. Cancers, 17.","DOI":"10.3390\/cancers17132117"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and Analysis of Cell-Cell Communication Using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2846\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:27:07Z","timestamp":1788427627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":41,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172846"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172846","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}